5-MeO-DMT Therapy

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Indications

Primary Indications

Major depressive disorder (including treatment-resistant subgroups)Anxiety disorders and end-of-life/existential distressPost-traumatic stress disorder (PTSD)Substance use disorders as an adjunct to psychotherapy

Mechanism

5-MeO-DMT is a potent serotonergic agent with activity at 5-HT1A and 5-HT2A receptors. The experience frequently includes rapid ego dissolution and non-dual states, which may disrupt rigid maladaptive patterns of self-referential processing. Hypothesized mechanisms include acute increases in neural entropy, modulation of default mode network dynamics, and downstream neuroplastic changes that, when integrated through psychotherapy, can translate into clinical improvement.

Protocol

Preparation

Comprehensive medical and psychiatric screening; medication review (e.g., MAOIs, SSRIs/SNRIs considerations per protocol); baseline vitals; informed consent; 1–3 preparatory psychotherapy sessions to set intentions and develop grounding skills.

Procedure

Arrival, re-screening, and baseline vitals
Calm, safe setting with two trained facilitators when possible
Administration route per protocol (commonly vaporized synthetic 5-MeO-DMT)
Continuous observation with supportive, non-directive facilitation
Gradual reorientation and early integration immediately post-experience

Frequency: Typically 1 session; some protocols allow 1–2 additional sessions several weeks apart

Duration: Psychedelic effects peak within minutes and resolve within 30–45 minutes; observation continues for 1–2+ hours

Total Treatment Time: 2–8 weeks including preparation and integration

Equipment

Medical-grade or study-approved delivery device (e.g., vaporizer/atomizer for synthetic formulation)
BP cuff, pulse oximeter; ECG available per protocol
Emergency response kit (oxygen, AED access, basic life support readiness)
Quiet, low-stimulus therapy room with comfortable recliner
Audio system for supportive soundscape (optional)

Session Structure

Pre-Session

Intention setting, review of coping strategies, mindfulness or breath training, safety check

Post-Session

De-brief, hydration/snack, initial integration conversation, safety assessment for discharge

Expected Outcomes

Immediate

Intense non-ordinary consciousness
Ego dissolution
Altered time/sensory perception

Short Term

Reduced anxiety and depressive symptoms (subset)
Increased connectedness/meaning
Emotional catharsis or relief

Long Term

Sustained improvements in mood/anxiety for responders
Shifts in life priorities/values
Enhanced well-being and spiritual integration when supported by therapy

Side Effects

common

Transient anxiety or fear during onset
Nausea
Dizziness
Headache
Fatigue post-session

uncommon

Hypertension/tachycardia (transient)
Psychological overwhelm or dissociation
Muscle tremors

rare

Prolonged dysphoria or derealization in vulnerable individuals
Medical complications in those with occult cardiovascular disease

Contraindications

absolute

History of psychosis or bipolar I disorder
Significant cardiovascular disease or uncontrolled hypertension
Pregnancy/breastfeeding
Recent severe TBI or intracranial pathology per protocol

relative

Strong family history of psychotic disorders
Severe personality pathology with affective instability
Concurrent substances/medications that raise risk (per protocol)

special considerations

Synthetic sources are preferred in research to ensure dosing accuracy and safety; animal-derived material is not appropriate in clinical research settings.
Robust preparation and integration substantially reduce risk of adverse psychological reactions.

Patient Selection

ideal candidates

Adults with mood/anxiety disorders who have not responded to standard care
Individuals with trauma histories who are stable, supported, and motivated for integration work
Patients experiencing end-of-life anxiety seeking existential support within a clinical framework

screening required

Medical evaluation and vitals
Psychiatric assessment with risk stratification
Medication/substance use review
Informed consent with discussion of intensity and alternatives

Training Requirements

practitioner

Formal training in psychedelic-assisted therapy
Trauma-informed psychotherapy skills
Competence in crisis management and de-escalation
Familiarity with 5-MeO-DMT pharmacology and adverse event protocols

facility

Quiet, medically supported setting
Emergency equipment and response plan
Integration therapy infrastructure and referral network

Research Evidence

Key Studies

Observational and survey research suggests rapid reductions in depression and anxiety post-5-MeO-DMT exposure (non-clinical and ceremonial contexts).
Early clinical protocols are exploring dosing, safety, and efficacy for mood and anxiety disorders.
Methodological limitations include self-selection, expectancy, and heterogeneous settings; blinded randomized trials are needed.

Limitations

Limited RCT data; variable set/setting and dosing across contexts; safety requires rigorous screening and medical readiness.

Cost Considerations

typical session cost: Not standardized; in clinical research, medication is typically provided under protocol

total treatment cost: Varies by study and number of therapy visits; may include screening and integration sessions

insurance coverage: Investigational—coverage generally unavailable outside approved research

cost effectiveness: Unknown pending definitive efficacy and durability data

ux display: undefined

collapsible: undefined

heading: undefined

Integration Support

Concurrent Therapies

Trauma-informed psychotherapy (e.g., EMDR, somatic approaches)
CBT/ACT for mood/anxiety
Mindfulness-based interventions
Palliative/supportive care for end-of-life indications

Special Populations

👶Pregnancy

Contraindicated

Clinical Notes

The intensity and brevity of 5-MeO-DMT require meticulous preparation and integration to translate insights into durable change.
Use synthetic, precisely dosed formulations in research/clinical contexts; do not use animal-derived sources.
Establish clear emergency protocols and role assignments prior to dosing.
Assess for dissociation history; tailor grounding strategies accordingly.

This treatment information is for educational purposes only. Treatment decisions should be made in consultation with qualified healthcare professionals based on individual circumstances, symptoms, and medical history. Do not attempt treatment without professional guidance.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists